CANDICE MIDKIFF: Open Payments
NPI 1154054492 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 31 payments from 11 companies in 2025. Trend: 2023 $158 · 2024 $132 · 2025 $653
Food & beverage: $653
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $150 |
| ABBVIE INC. | 10 | $139 |
| Axsome Therapeutics, Inc. | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| SHIELD THERAPEUTICS INC | 2 | $43 |
| Astellas Pharma US Inc | 2 | $37 |
| PFIZER INC. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Lilly USA, LLC | 1 | $15 |
Products named: Wegovy, VRAYLAR, Auvelity, AIRSUPRA, REXULTI, ACCRUFER, Veozah, Ozempic.
Industry payments across LA — which companies pay providers there.
